関連する実験動画
Updated: Apr 19, 2026
08:49
Murine Ileocolic Bowel Resection with Primary Anastomosis
Published on: October 29, 2014
17.7K
腸切除後のクローン病の管理:ランダム化試験
Peter De Cruz1, Michael A Kamm2, Amy L Hamilton3
1Department of Gastroenterology, St Vincent's Hospital and Department of Medicine, University of Melbourne, Melbourne, VIC, Australia; Austin Health, University of Melbourne, Austin Academic Centre, Heidelberg, VIC, Australia.
Lancet (London, England)
|December 28, 2014
まとめ
早期介入による積極的なモニタリングは,小腸切除後の術後のクローン病の再発を大幅に減少させます. この戦略は,標準的なケアのみと比較して,内視鏡検査の結果を改善します.
科学分野:
- 胃腸内科 胃腸内科
- 外科腫瘍学外科腫瘍学
- クリニック・トライアル研究
背景:
- クローン病はしばしば腸切除を必要としますが,再発は一般的であり,さらなる手術につながります.
- 術後の再発を予防するための最適な戦略を特定することは,患者の管理に極めて重要です.
研究 の 目的:
- 早期の結腸鏡検査と治療調整を伴うアクティブケア戦略の有効性を評価し,手術後のクローン病の再発を予防する標準治療と比較した.
主な方法:
- クローン病のために腸切除を受けた174人の患者を対象としたランダム化試験.
- 患者は初期治療 (メトロニダゾール,チオプリンまたはアダリムマブを含む高リスク患者) を受けました.
- アクティブケア (再発の治療をステップアップする6ヶ月のコロノスコピー) または標準ケア (ルーティンコロノスコピーなし) にランダム化.
主要な成果:
- 18ヶ月後の内視鏡再発は,標準治療 (67%) と比較して,アクティブケアグループ (49%) で著しく減少しました.
- 粘膜の完全な正常化は,アクティブケアグループでより頻繁に達成されました (22%対8%).
- 喫煙と複数の臨床的リスク要因は,再発リスクの増加と関連していました.
結論:
- 早期の内視鏡検査と調整された治療エスカレーションを含むアクティブケアアプローチは,手術後のクローン病の再発を予防するために,従来の治療法よりも優れています.
- 定期的な使用ではなく,早期再発に調整された選択的免疫抑制は,病気のコントロールを助けます.
- 継続的なモニタリングは,低リスク患者または初期寛解を達成した患者でも不可欠です.
関連する概念動画
01:21Inflammatory Bowel Disease V: Surgical Management
905
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
905
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
1.1K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
1.0K
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
1.0K
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.6K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
01:25Inflammatory Bowel Disease III: Crohn's Disease
2
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
2
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
738
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
738